Resmed Inc
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.
Earnings per share grew at a 23.0% CAGR.
Current Price
$209.43
+2.15%GoodMoat Value
$331.31
58.2% undervaluedResmed Inc (RMD) Quality Analysis
RMD Profitability
RMD Growth
RMD Financial Health
RMD Quality & Fundamental Analysis
Resmed Inc (RMD) is a Healthcare company in the Medical Instruments & Supplies industry, listed on NYSE. This quality analysis page evaluates Resmed Inc's financial health using the Piotroski F-Score methodology, profitability ratios, growth trajectory, and balance sheet strength.
Resmed Inc has a Piotroski F-Score of N/A out of 9, measuring profitability, leverage, and operating efficiency. The company operates with a profit margin of 27.44% and a return on equity (ROE) of 25.46%. Return on assets (ROA) stands at 18.59%.
The debt-to-equity ratio is 0.14, with a current ratio of 3.44. Operating margin is 32.75%.
GoodMoat's quality analysis uses AI-powered insights to evaluate whether Resmed Inc is a fundamentally sound investment. The GoodMoat Verdict synthesizes profitability, growth, and financial health scores into a clear investment quality rating. Use these metrics alongside valuation tools like the DCF calculator and fair value models to make informed investment decisions.